I13006—Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine

Contact:

Mentor:  Gang Liu, MD, Ph.D, Assistant Professor, Department of Medicine, Division of Pulmonary, Allergy, and Critical care Medicine, University of Alabama at Birmingham, BMR2 304, 901 19th St. So., Birmingham, Alabama 35294, Tel: 205-975-8932, Fax: 205-934-7437, E-mail: gliu@uab.edu.


Postdoctoral fellow position open to study the role of microRNAs in the regulation of pulmonary fibrosis and inflammation. The major focus of the lab is to characterize the role of individual miRNA and epithelial cells, and inflammatory cells, such as macrophages. The individual should have experience designing, interpreting, and performing experiments using various molecular and cellular biology techniques. Prior experience with mice is preferred. Research in the lab is supported by grants from NIH. The successful candidate is expected to perform and design experiments with minimal input from the mentor, and to write manuscripts for publication and presentation. The successful candidate must be highly self-motivated and interested in pursuing an independent research career. Ph.D. and/or M.D. degree required. Applicants should submit their CV and the names and contact information of three references to Gang Liu, M.D., Ph.D., Associate Professor, Department of Medicine, Division of Pulmonary, Allergy, and Critical care Medicine, University of Alabama at Birmingham, BMR2 233, 901 19th St. So., Birmingham, Alabama 35294, Tel: 205-975-8932, Fax: 205-934-7437, E-mail: gliu@uab.edu.

UAB News

  • According to Bruce Korf, M.D., Ph.D., chair of the department of genetics, and director of the Heflin Center for Genomic Sciences at the University of Alabama at Birmingham, the glut of genetic information that will be used to inform treatment decisions will require additional education of clinicians, especially since a sizable cohort received their genetics training before the genomic age.

  • "If someone has hepatitis C and does not know it, it could be doing damage to their liver," says Michael Saag, MD, professor of medicine and director of the Center for AIDS Research at the University of Alabama at Birmingham. He is also co-chair of the Infectious Diseases Society of America's HCV Guidance panel.